Multiple Sclerosis Discovery Forum
  News and Future Directions
  Papers
  Forums
  Professional Resources
  Research Resources
MSGene - Gene overview of all published MS-association studies for IL10
Back Search Methods Disclaimer Credits
 Gene: IL10  (CSIF; IL-10; IL10A; MGC126450; MGC126451; TGIF)  Entrez Gene    View on AlzGene   View on PDGene   View on SZGene
 Protein: interleukin 10  (cytokine synthesis inhibitory factor)  ProteinLink
 Chromosome: 1   (View: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  X  Y  MT)
 Status: Updated 25 November 2011
Meta-Analysis
1. Case-Control Studies (by ethnic group)
      MS Cases Normal Controls  
Study Population Source # Polys # Subjects
(% women)		 DX Onset Age
(range)		 Age
(range)		 # Subjects
(% women)		 Age
(range)		 Result
 Caucasian
Almeras, 2002
 France CL  2  (detail)  153
(69%)		P33.1
(-)		39.5 + 10.8
(16-69)		184
(58%)		29.9 + 7
(18-62)		Positive
Azarpira, 2010
 Iran CL  3  (detail)  110
(71%)		P-32.2
(-)		100
(51%)		33.4
(-)		Negative
Baranzini, 2008
 USA, Netherlands, Switzerland (GWAS) CL  1  (detail)  978
(67%)		MD1&234
(11-61)		47
(21-69)		883
(66%)		46
(21-69)		Negative
De Jong, 2002
 Overlaps with
Baranzini, 2008 (Netherlands)		 CL  5  (detail)  251
(59%)		P33.5 + 9.6
(-)		47.5 + 11.3
(-)		321
(47%)		39 + 17
(-)		Positive
Doncel, 2002
 Spain CL  5  (detail)  300
(67%)		P--357
(-)		-Trend
Forte, 2006
 Italy CL  1  (detail)  91
(-)		U--220
(-)		-Negative
He, 1998
 Sweden CL  1  (detail)  147
(-)		P--95
(-)		-Negative
Luomala, 2003
 Finland CL  1  (detail)  116
(58%)		P-46 + 10
(24-78)		400
(-)		-Positive
Maeurer, 2000
 Germany CL  1  (detail)  181
(-)		U--85
(-)		-Negative
McDonnell, 2000
 UK (Northern Ireland) CL  1  (detail)  287
(-)		P--216
(-)		-Negative
Mihailova, 2005
 Bulgaria CL  3  (detail)  55
(56%)		P27.3 + 7.1
(-)		32.3 + 9.5
(-)		86
(-)		-Positive
Mirowska-Guzel, 2011
 Poland CL  1  (detail)  230
(73%)		MD1&229 + 9.9
(-)		38.1 + 10.9
(-)		195
(67%)		40 + 10.1
(-)		Negative
Motsinger, 2007
 USA CL  1  (detail)  421
(-)		MD1--96
(-)		-Negative
Myhr, 2002
 Norway PO  3  (detail)  168
(65%)		P32.5 + 0.6
(-)		46.9
(-)		87
(-)		-Trend
Pickard, 1999
 UK CL  4  (detail)  185
(74%)		P31.4 + 9
(-)		41.7 + 10.6
(-)		211
(-)		-Negative
 African Descent
Brassat, 2006
 USA CL  1  (detail)  442
(-)		MD1--293
(-)		-Negative
 Other/Mixed
Amirzargar, 2007
 Iran CL  3  (detail)  44
(68%)		P--140
(-)		-Negative
Izad, 2010
 Overlaps with
Amirzargar, 2007		 CL  3  (detail)  98
(66%)		P27.3 + 9.7
(-)		37.7 + 10.4
(-)		97
(42%)		25 + 20
(-)		n.a.
Contact us if you are an author of an association study regarding this gene and do not find your study in this table or find errors in the representation of your study details.
2. Family-Based Studies (by ethnic group)
      Affecteds Unaffecteds  
Study Population # Polys # Families # Subjects
(% women)		 DX Onset Age
(range)		 Age
(range)		 # Subjects
(% women)		 Age
(range)		 Result
 Caucasian
Barcellos, 2004
 Overlaps with
Motsinger, 2007 (CC)		  1  (detail)  337337
(-)		U----Negative
Doncel, 2002
 Overlaps with
Doncel, 2002 (CC)		  5  (detail)  63-P----Negative
Motsinger, 2007
 Overlaps with
Motsinger, 2007 (CC)		  1  (detail)  275-MD1----n.a.
Motsinger, 2007
 Overlaps with
Motsinger, 2007 (CC)		  1  (detail)  146146
(-)		MD1----n.a.
Contact us if you are an author of an association study regarding this gene and do not find your study in this table or find errors in the representation of your study details.
Source:  Source of case population -> “CL” (clinic-based), “PO” (population-based), or “CO” (community-based).
# Polys:  Number of polymorphisms tested per gene and per sample.
Onset Age and Age:  Mean or median age at onset or examination, respectively.
DX:  Criteria used to determine MS diagnosis ->  "P" (Poser criteria, 1983), "MD1" (McDonald criteria, 2001), "MD2" (revised McDonald criteria, 2005), "MD1&2" (McDonald criteria, 2001 and 2005), "O/M" (other/mixed), "U" (Unknown).
Result:  Overall conclusion reached by authors of the original publication (“positive” usually indicates significant (P<0.05) association in at least one of the performed analyses, and “negative” indicates no evidence for significant association, while “trend” indicates results in between).
(-) :  Either no data provided or in case of overlap, data included in original study.
Print this page
Email this page
MSDF RSS

Text size
Share & Bookmark
MSGene Recent Updates
MSGene Top Results
Top Results Details
1. HLA-DRB1
2. IL2RA
3. IL7R
4. TAGAP
5. CLEC16A
6. EVI5
7. GWA_16q24.1
8. GWA_5p13.1
9. TTC34
10. AHI1   
[see more]
MSGene Stats
Studies: 789
Genes: 809
Polymorphisms: 2907
Meta-analyses: 324
ALSGene
AlzGene
MSGene
PDGene
SZGene
An up-to-date collection of all published genetic association studies.
Copyright © 2024 Biomedical Research Forum LLC Disclaimer Copyright